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Photoluminescent Cationic 
Carbon Dots as efficient Non-Viral 
Delivery of Plasmid SOX9 and 
Chondrogenesis of Fibroblasts
Xia Cao1, Jianping Wang1, Wenwen Deng1, Jingjing Chen1, Yan Wang1, Jie Zhou1, Pan Du1, 
Wenqian Xu1, Qiang Wang1, Qilong Wang1, Qingtong Yu1, Myron Spector2, Jiangnan Yu1 & 
Ximing Xu  1
With the increasing demand for higher gene carrier performance, a multifunctional vector could 
immensely simplify gene delivery for disease treatment; nevertheless, the current non- viral vectors lack 
self-tracking ability. Here, a type of novel, dual-functional cationic carbon dots (CDs), produced through 
one-step, microwave-assisted pyrolysis of arginine and glucose, have been utilized as both a self-
imaging agent and a non-viral gene vector for chondrogenesis from fibroblasts. The cationic CDs could 
condense the model gene plasmid SOX9 (pSOX9) to form ultra-small (10–30 nm) nanoparticles which 
possessed several favorable properties, including high solubility, tunable fluorescence, high yield, low 
cytotoxicity and outstanding biocompatibility. The MTT assay indicated that CDs/pSOX9 nanoparticles 
had little cytotoxicity against mouse embryonic fibroblasts (MEFs) compared to Lipofectamine2000 and 
PEI (25 kDa). Importantly, the CDs/pSOX9 nanoparticles with tunable fluorescence not only enabled the 
intracellular tracking of the nanoparticles, but also could successfully deliver the pSOX9 into MEFs with 
significantly high efficiency. Furthermore, the CDs/pSOX9 nanoparticles-mediated transfection of MEFs 
showed obvious chondrogenic differentiation. Altogether, these findings demonstrated that the CDs 
prepared in this study could serve as a paradigmatic example of the dual-functional reagent for both 
self-imaging and effective non-viral gene delivery.
Gene therapy has attracted considerable attention in the medical, pharmaceutical and biotechnological fields 
due to its potential to treat a plethora of chronic and genetic diseases1,2. The basic principle of gene therapy is 
to correct the origin of diseases via the delivery and subsequent expression of exogenous DNA encoding for 
the missing or defective gene product. In this regard, developing effective gene vectors has become essential 
for the improvement of gene delivery efficiency. To date, gene delivery vehicles can be classified as viral and 
non-viral vectors3–5. Generally, viral agents possess high transfection efficiency but suffer from significant limi-
tations due to the high likelihood of mutagenesis or carcinogenesis6. However, these shortcomings are virtually 
absent in non-viral vectors such as cationic liposomes7,8, cationic polymers9–11, and inorganic nanoparticles (such 
as calcium phosphate nanoparticles)12, which offer a more efficient and safer alternative in conjunction with 
enhanced transfection efficiency. With the increasing demand for higher gene carrier performance, a multifunc-
tional vector that integrates low toxicity, high transfection efficiency and bioimaging could immensely simplify 
gene delivery for disease treatment. Therefore, the additional benefit of bioimaging allows the self-tracking of the 
DNA-loaded complexes, which is desirable for gene delivery. However, the before mentioned non-viral vectors 
lack this self-tracking ability.
To bridge this gap, this study focuses on the utilization of fluorescent semiconductor quantum dots (QDs) for 
efficient non-viral gene delivery. QDs are a type of semiconductor crystal ranging from 2 to 10 nm in diameter 
and are one of the first nanotechnologies used in biological sciences13–15. Nevertheless, the most conventional 
1Department of Pharmaceutics, School of Pharmacy, and Center for Drug/Gene Delivery and Tissue Engineering, 
Jiangsu University, Zhenjiang, 212001, P.R. China. 2Department of Orthopedic Surgery, Harvard Medical School, 
Brigham and Women’s Hospital, 75 Francis St, Boston, MA, 02115, USA. Xia Cao, Jianping Wang, Wenwen Deng and 
Jingjing Chen contributed equally to this work. Correspondence and requests for materials should be addressed to 
X.X. (email: xmxu@ujs.edu.cn)
Received: 17 October 2016
Accepted: 19 April 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCiEnTifiC RePoRtS |  (2018) 8:7057  | DOI:10.1038/s41598-018-25330-x
semiconductor QDs contain metallic elements, which restricts their application due to concerns regarding their 
toxicity, stability and environmental implications16. Consequently, the development of benign nano-materials 
(i.e., the substitution of metals with carbon) exhibiting optical properties that are similar to those of QDs has 
inspired several comprehensive studies17,18. Admittedly, several studies have investigated CDs; however, none 
of these studies has reported on the direct use of these particles for gene applications19, with the exception of 
PEI modification for gene delivery20. Currently, the two major routes for the synthesis of CDs are top-down and 
bottom- up approaches. The top-down approach involves the formation of CDs from larger carbon structures 
via a post-treatment carbon breakdown process such as electrochemical oxidation21,22, laser ablation23,24 or arc 
discharge25. In the bottom-up approach, CDs are obtained from suitable molecular precursors via ultrasonic 
treatment26, acid dehydration27, thermal carbonization28 or combustion6,29. However, the major obstacles to the 
application of QDs are the highly demanding preparation procedures and the complex modification of these 
substances required for effective gene binding. To this end, this study reports the one-step synthesis of cationic 
CDs as nano-gene vectors from simple precursors, glucose and arginine, using microwave-assisted pyrolysis. This 
method is a special type of bottom-up technique that does not consume large amounts of energy and generates 
appreciable yields. The developed CDs were subsequently utilized to deliver a plasmid containing the gene for 
SOX9 into mouse embryo fibroblasts (MEFs) to investigate the potential of differentiation into chondrocytes.
The transcription factor SOX9 is a member of the SOX (SRY-type HMGbox) protein family and plays an 
essential role in chondrogenesis30 and regulates the formation of numerous cell types, tissues and organs, includ-
ing hair follicles, testes and the heart31. SOX9 is expressed in all chondroprogenitor cells of the mouse embryo; 
however, its expression is abolished in hypertrophic chondrocytes and osteoblasts32. Previous studies have 
reported that SOX9 gene transfer promoted in vitro chondrocyte differentiation and cartilage formation; however, 
the vehicles used for SOX9 gene delivery were viruses, which carries potential safety risks when applied in clinical 
trials33,34. Therefore, the development of a safer and more effective vehicle to facilitate gene delivery is urgently 
needed. Primary MEFs, which are typically isolated from 12- to 14-day mid-gestation mouse embryos, have been 
previously investigated for cell commitment and differentiation into mesenchymal lineages, such as cartilage and 
adipose tissues35. Although MEFs have previously been reported to undergo chondrogenic differentiation, most 
of the strategies were based on viral transfection36 or protein factors37,38, which suffered from either safety issues 
or a lack of efficiency.
In this issue, CDs were used for the first time as a non-viral vector to deliver pSOX9 (Fig. 6) into MEFs for 
chondrogenic differentiation with high efficiency and low cytotoxicity, with an additional self-tracking feature 
for bioimaging.
Materials and Methods
Materials. Dulbecco’s Modified Eagle Medium/F-12 (DMEM/F12) and trypsin were purchased from 
Invitrogen (Invitrogen, USA). Fetal bovine serum (FBS) was purchased from Gibco (Gibco, USA). SOX9 was 
purchased from Bioworld Technology, Inc. (Nanjing, China). The ELISA kit for SOX9 quantification was pur-
chased from Nanjing Qiteng Biological Co., Ltd. (Nanjing, China). MTT was purchased from Sigma (Sigma, 
USA). Quinine, sulfuric acid solution (H2SO4), ammonium chloride (NH4Cl), acrylamide, sodium orthovanadate 
(SOV), glucose, and colchicine were all obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). 
Cytochalasin D was obtained from J&K Scientific (Beijing, China).
YOYO-1 was purchased from Invitrogen (Invitrogen, USA). Arginine (ultrapure, molecular biology grade) 
was purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). All other reagents were pur-
chased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Principles of laboratory animal care were 
followed and all procedures were conducted according to the guidelines established by the National Institutes of 
Health, and every effort was made to minimize suffering. This study was approved by the Animal Experiment 
Committee of Jiangsu University.
Cell lines. Primary MEFs were extracted from 12- to 14-day mid-gestation Kunming mice (Laboratory 
Animal Center of Jiangsu University, Zhenjiang, China) according to the procedures previously described39. The 
MEFs were cultured in DMEM/F12 (Gibco, USA) supplemented with 10% FBS at 37 °C in a 5% CO2 atmosphere.
Preparation of carbon quantum dots. The CDs were synthesized using a microwave- assisted pyrolysis 
method. Briefly, arginine and glucose (0.1 g) were mixed in various weight ratios (3:1, 6:1, 9:1, 12:1, and 15:1) with 
30 mL of double distilled water under ultrasonication to form a homogeneous solution which was heated with a 
commercial microwave oven (700 W, Galanz, China) for 10 min. After cooling to room temperature, the sample 
was diluted with distilled water at an appropriate ratio and dialyzed against double distilled water for 4 days. The 
product was concentrated, filtered through a 0.22-µm filter and freeze dried (Christ Alpha 2–4, Germany) to yield 
highly fluorescent CDs.
Determination of fluorescence quantum yields. Fluorescence quantum yield is defined as the ratio 
of the number of radiated photons to the number of absorbed photons. In this study, the fluorescence quantum 
yields of CDs were determined using a comparative method. Quinine sulfate was selected as the standard due to 
its chemical stability, high quantum yield and lack of overlap between its excitation and emission spectra. The PL 
emission spectra of all of the samples were measured using an RF-5310 spectrofluorophotometer (SHIMADZU, 
Japan) at an excitation wavelength corresponding to the UV range. The integrated fluorescence intensity is the 
area under the PL curve over the wavelength range of 380 to700 nm. Absolute values were calculated according 
to the following equation19:
www.nature.com/scientificreports/
3SCiEnTifiC RePoRtS |  (2018) 8:7057  | DOI:10.1038/s41598-018-25330-x
= × ×Yu Ys (Fu/Fs) (As/Au),
where Yu is the quantum yield of the test sample and Ys is the quantum yield of the standard sample; Fu and Fs 
are the integrated fluorescence intensities of the test and standard samples, respectively; and As and Au are the 
absorbance values of the test and standard samples, respectively.
Preparation and characterization of CDs/pSOX9 nanoparticles. A 2 mg/mL solution of CDs was 
prepared using double distilled water and sterilized through a 0.22-µm filter prior to use. The CDs/pSOX9 nan-
oparticles were formulated at various weight ratios of CDs/pSOX9 by adding predetermined concentrations of 
sterilized CDs to a well-defined pDNA solution. The product was vortexed to form a homogeneous mixture. The 
mixtures were then incubated at room temperature for 20 min to allow for the formation of nanoparticles.
For morphological characterization, the transmission electron microscopy (TEM) images of CDs and CDs/pSOX9 
nanoparticles were obtained using a JEM-2100 transmission electron microscope (JEOL, Japan) operated at an 
accelerating voltage of 40–100 kV. Fourier transform infrared spectroscopy (FT-IR) spectra were measured using 
an Avatar 370 instrument (Nicolet, USA) to indicate the structural changes from the original materials (arginine 
and glucose) to the resultant CDs. The hydrodynamic sizes and surface charges of the CDs and CDs/pSOX9 nan-
oparticles were determined using a Zetasizer Nano (Malvern Instruments, Malvern, UK). The fluorescence spec-
tra of the CDs were obtained using a spectrofluorophotometer (RF-5301PC, SHIMADZU), and the absorbance 
spectra were recorded using a UV-Vis spectrophotometer (UV-2550, SHIMADZU, Japan).
Agarose gel electrophoresis. The binding of pDNA with CDs was evaluated using agarose gel electropho-
resis. The CDs/pSOX9 nanoparticles were freshly prepared at different weight ratios as described in the section of 
Preparation of CDs/pSOX9 nanoparticles. After 5 min of incubation at room temperature, 10 µL of the complex 
solution was mixed with 2 µL of loading buffer. The resultant mixture was loaded onto a 1% agarose gel containing 
ethidium bromide (0.5 µg/mL) buffer at 80 V for 40 min, and the gel was visualized under a UV transilluminator 
at a wavelength of 365 nm. The pDNA in this study referred to the pSOX9 unless otherwise specified.
Cytotoxicity. The in vitro cytotoxicity of the CDs/pSOX9 nanoparticles against the MEFs was evaluated using 
the MTT assay. In brief, the MEFs were seeded into a 96-well culture plate at an initial density of 5 × 104 cells/well 
and incubated for 24 h under the same conditions used for cell culture. The CDs/pSOX9 nanoparticles were 
then freshly prepared at different weight ratios (1:1, 10:1, 100:1, 500:1, and 1000:1), followed by dilution with the 
serum-free medium. 100 µL of the nanoparticle-containing, serum-free medium was added to each well (0.2 µg 
of pDNA for each well) and incubated for 4 h. After removal of the nanoparticle-containing medium, the cells 
were incubated with the 10% FBS-containing medium for 72 h. After that, 20 µL of the MTT solution (5 mg/mL) 
was added to each well and incubated for another 4 h. The medium was then removed, and 100 µL of dimethyl 
sulfoxide was added to form a formazan crystal salt solution. The absorbance of each well was measured using a 
microplate reader at 570 nm (Epoch, BioTek, USA). The PEI modified CDs (PEI-CDs)/pSOX9 complexes were 
prepared as previously described19 and used as a control in the cytotoxicity assay as well as the subsequent trans-
fection evaluation.
Localization of complexes. The intracellular distribution of the complexes was evaluated using the con-
focal microscopy. The MEFs were seeded into 24-well culture plates at an initial density of 2.5 × 105 cells/well 
and incubated for 24 h under the same conditions used for cell culture. The nucleic acid fluorescent dye YOYO-1 
was used to label free plasmid DNA and the CDs/pSOX9 nanoparticles. The YOYO-1-labeled nanoparticles and 
plasmid DNA were added to the respective wells, and the plates were slightly shaken to create a uniform mixture. 
After incubation at 37 °C in 5% CO2 for different durations (4, 8 and 24 h), the cells were fixed with 4% para-
formaldehyde and then visualized using a confocal laser microscope (Leica, DMI6000B, Germany) with three 
solid-state lasers (405, 488, and 514 nm).
Pathways for cellular uptake of the CDs/pDNA complexes. To obtain a preliminary understanding 
of the mechanisms of the CDs internalization, four inhibitors were used to examine the cellular uptake pathways 
of the CDs/pSOX9 nanoparticles, including filipin III, glucose, 5-(N,N-dimethyl)-amiloride (DMA), and chlor-
promazine hydrochloride (CPZ). The inhibitory functions and concentrations of these inhibitors are summa-
rized in Table 1. Following incubation with these inhibitors at 37 °C for 2 h, the culture medium in each well was 
replaced with 10% FBS-containing DMEM/F12 medium. After an additional 24 h, the cells were observed using 
a fluorescence microscope (Leica, DMI6000B, Germany).
The intracellular distribution of the complexes was evaluated using the flow cytometry (FCM). The MEFs were 
seeded into 6-well culture plates at an initial density of 2.5 × 105 cells/well and incubated for 24 h under the same 
conditions using cell culture. The YOYO-1-labeled nanoparticles and plasmid DNA were added to the respective 
wells, and the plates were slightly shaken to create a uniform mixture. After incubation at 37 °C in 5% CO2 for 
24 h), the cells were viewed under a FCM (BD 6 plus) with three solid-state lasers (488 nm).
In vitro transfection. The MEFs were used to evaluate the transfection efficiency of the CDs/pSOX9 nan-
oparticles. Specifically, the MEFs were seeded into 96-well culture plates at an initial density of 5 × 104 cells/well 
and incubated for 24 h under the same conditions used for cell culture. Four hours prior to transfection, the 
medium in each well was replaced with 100 µL of serum-free medium. The CDs/pSOX9 nanoparticles (0.2 µg of 
pDNA for each well) at various weight ratios (1:1, 50:1, and 100:1) were added to the wells. The transfection rea-
gents PEI (25 kDa) and Lipofectamine2000 were used as positive controls according to the procedures provided 
by the manufacturers. After incubation at 37 °C in 5% CO2 for 4 h, the medium in each well was replaced with 
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100 µL of 10% FBS-containing medium, and the cells were incubated for another 72 h. After that, the medium 
was collected and centrifuged for 5 min at 1500 rpm to obtain the supernatant. The expression level of SOX9 was 
quantified using the ELISA kit according to the manufacturer’s instructions, and the plate was read at 450 nm 
using a microplate reader.
MEFs differentiation into cartilage cells. The MEFs were seeded on a 24-well plate at an initial density 
of 2.5 × 105 cells/well and incubated for 24 h to obtain a confluence of 60- 70%. The cells were then transfected 
with the CDs/pSOX9 nanoparticles at a ratio of 40:1 (0.8 µg of pSOX9 per well) as presented in section In vitro 
transfection. The medium was replaced every two days. The cells were transfected once when the samples were 
collected on day 3, twice when collected on day 7 and four times when collected on day 14 and were fixed with 4% 
paraformaldehyde at 4 °C for subsequent evaluation. The samples fixed on day 14 were visualized using a confocal 
laser microscope with three solid-state lasers (405, 488 and 514 nm).
Immunolocalization of collagen II expression in the transfected MEFs was performed using a commercial 
streptavidin-biotin complex (SABC) kit (Boster, Wuhan, China). According to the manufacturer’s instructions, 
each sample was incubated in normal goat serum for 20 min at room temperature, followed by incubation with 
rabbit polyclonal antibodies against mouse collagen II (Abcam, Cambridge, MA) at a dilution of 1:500 in PBS 
overnight at 4 °C. After washing three times with PBS, the cells were incubated with biotinylated goat anti-rabbit 
IgG for 20 min at 37 °C. Then, the cells were exposed to SABC and stained with 3, 3-diaminobenzidine (DAB) 
(Boster, Wuhan, China). For the control staining, PBS was used instead of the primary antibody.
The metachromatic dye toluidine blue was used to stain cartilage cells generated from the transfected MEFs. 
Toluidine blue (Toluidine Blue O, Sigma-Aldrich; 1% NaCl, pH = 2.3) was added to the fixed plates for 5 min at 
ambient temperature40. Western blotting of collagen II was tested in transfected MEFs on days 3, 7 and 14, while 
un-transfected MEFs was used as a control.
Immunogenicity test. Twenty (20) male mice were given 0.2 ml CDs/pDNA by intravenous injection and 
observed under 24 h. The concentration of CDs was 100 fold of cell transfection. After 24 h, the mice eyeballs were 
extracted and whole blood was taken and the blood cells counted.
Statistical analysis. All data were presented as mean ± standard deviation (SD). The Students t-test was 
performed to determine the significance (a p < 0.05 was considered statistically significant) of the differences 
between the selected groups using the statistical software of SPSS 14.0 (SPSS company, USA).
Results and Discussion
Characterization of CDs. The CDs exhibited excellent water-soluble properties41 with blue luminescence 
emission (Fig. 1a). The FT-IR spectra analysis demonstrated that the CDs combined the characteristic IR absorp-
tions from the both starting materials (arginine and glucose): the broad absorption band ranging from 3000 cm-1 
to 3410 cm−1 (the vibration of N-H and O-H groups), 1459 cm−1 (bending vibration of –CH2–),1377 cm−1 (sym-
metrical deformation vibration of –CH3) in both arginine and glucose (Fig. 1b). Meanwhile, a new, strong peak 
at 1630 cm−1 which may be attributed to the C=O groups emerged in the CDs’ spectrum (Fig. 1b), indicating the 
chemical reactions occurred during the preparation of the CDs and the arginine residues have been successfully 
grafted onto the surface of the CDs in situ. Previous reports have shown that surface passivation plays a key role in 
the combination of CDs and pDNA23. PEI which has usually been used as a gene carrier in spite of a certain level 
of cytotoxicity has also been widely employed as a passivating agent during the preparation of CDs20,42. The result 
of zeta potential test revealed that the CDs produced in this study possessed a positive charge (25.4 ± 0.3 mV) 
(Fig. 1c) without surface passivation. This is likely due to the presence of amino groups on the CDs surface.
The positive charge of the CDs is required for the combination with the negatively charged DNA. To test this, 
Zeta potential and agarose gel electrophoresis was performed to examine the effective combination of CDs and 
pDNA with a series of weight ratios. The finding demonstrated that the distance of pDNA migration across the 
agarose gel gradually decreased with an increasing CDs/pDNA weight ratio (1:1, 3:1, 6:1, 9:1 and 12:1); when 
this ratio increased to 9:1, the pDNA was completely retained in the original well, suggesting minimum effective 
weight ratio that prevented DNA migration was 9:1 (Fig. 1e). The CDs/pDNA complex still cannot keep pDNA 
in the original location until the 9:1 weight ratio, and this could be due that one pDNA molecule might combined 
with several CDs while other pDNA are still in free form. So it is observed that all zeta potential of the complex 
are positive, meaning the amount of CDs is not sufficient to coat all the pDNA until the 9:1mass ratio is attained. 
Moreover, the CDs/pDNA nanoparticles (9:1) also showed a positive charge (21.8 ± 0.2 mV) (Fig. 1d), which 
would facilitate the cellular uptake of the CDs/pDNA nanoparticles.
The quantum yield was determined by employing quinine sulfate (quantum yield of 54%) as a standard sam-
ple, and the result showed that the CDs enjoyed a quantum yield of 12.7%, which was comparable to previous 
reports43.
Name Function Final concentration
Glucose Inhibits clathrin-dependent endocytosis 0.45 M
CPZ Inhibits clathrin-dependent endocytosis 10.0 μg/ml
DMA Inhibits the Na
+/H+ exchange required for 
macropinocytosis 10 μM
Filipin III Blocks caveolae/raft-mediated endocytosis 1 μg/ml
Table 1. Inhibitors and their Function and Concentration.
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The morphology of the CDs before and after combination with the pDNA was observed with TEM. As shown 
in Fig. 1f, the CDs (panel 1) and CDs/pSOX9 nanoparticles (panel 2) were uniformly distributed and had a 
spherical or elliptical morphology. The particle size determination by dynamic light scattering technique showed 
that these CDs (with diameters within the range of 1–7 nm, Fig. 1g) and CDs/pSOX9 nanoparticles (10–30 nm 
in diameter, Fig. 1g) both possessed an ultra small particle size, which is consistent with the TEM analysis. When 
positively charge CDs solution was mixed with negatively charge pDNA solution a homogeneous mixture is 
formed. The two oppositely charged ions combined to form nanoparticles. The addition of the two solutions 
resulted in charge neutralization, bridging and aggregation and this might have led to size decrease. Hence, the 
particle size ratio reduced from 3:1 to 9:1 (CDs:pDNA) Thereafter, with more addition of CDs, the levels of posi-
tively charged CDs increase with respect to negatively charged pDNA resulting in low charge neutralization and 
static repulsion. The particle size therefore increased from the ratios 9:1 to 15:1(S2). Additionally, the combina-
tion of CDs and pDNA generated a strong fluorescence intensity that was similar to that of CDs alone (Fig. 1h), 
indicating that the combination with pDNA did not significantly affect the CDs fluorescence.
Cytotoxicity. The integration of transfection ability and effective bioimaging into a single CD nano vector 
requires not only suitable optical and delivery properties but also low cytotoxicity. Previously reported CDs which 
have been usually been passivated by PEI exhibited dose- dependent cytotoxicity43. However, the CDs prepared in 
this study avoid this problem with no surface passivation.
To evaluate the cytotoxicity of the CDs, the relative viabilities of MEFs exposed to CDs were determined 
using an MTT assay. The PEI-CDs and PEI (25 kDa) were used as controls. As shown in Fig. 2a, the CDs/pSOX9 
nanoparticles exhibited no cytotoxicity when the CDs/pDNA weight ratio was increased from 1:1 to 500:1 (far 
surpassed the weight ratio used in transfection assay), followed by an acceptable dose-dependent cytotoxicity. 
Moreover, apoptosis was not observed for the CDs/pSOX9 nanoparticles at weight ratios of 1:1, 10:1, 100:1 and 
500:1 (Fig. 2a). In contrast, both the PEI-CDs and PEI (25 kDa) showed significantly decreased cell viability when 
compared with the CDs (Fig. 2b). The cell viability of the CDs/pSOX9 nanoparticles was superior to that of PEI 
(25 kDa) even at a CDs/pSOX9 weight ratio of 1000:1. These results indicated that the CDs prepared in this study 
had an excellent biocompatibility.
Figure 1. Characterization of CDs and CDs/pDNA complexes. (a) Aqueous CDs solutions under UV light 
at 365 nm: 1, double distilled water; 2, CDs solution; (b) FT-IR spectra of glucose, arginine and CDs; (c) 
Zeta potential of free plasmid, CDs and CDs/pDNA complexes; (d) Zeta potential of CDs/pDNA complexes 
prepared at CDs/pDNA weight ratios of 3:1, 6:1, 9:1 12:1, and 15:1; (e) Agarose gel electrophoresis: CDs/pDNA 
complexes at different weight ratios (1:1, 3:1, 6:1, 9:1, and 12:1, from left to right); (f) TEM images: 1, CDs; 2, 
CDs/pDNA complexes; (g) Particle size distribution of CDs and CDs/pDNA complexes (2:1); (h) Aqueous CDs 
before (1) and after (2) complexation with pDNA under UV light at 365 nm. Values are the means ± SD of three 
repeated experiments.
www.nature.com/scientificreports/
6SCiEnTifiC RePoRtS |  (2018) 8:7057  | DOI:10.1038/s41598-018-25330-x
In vitro transfection. With the proper ratio of CDs/pDNA (S2), the CDs/pSOX9 nanoparticles with a weight 
ratio of 9:1 were used in the subsequent experiments. The PEI (25 kDa) and Lipofectamine2000 were used as 
controls, and the PEI-CDs were employed in parallel experiments.
The results revealed that the MEFs transfected with the CDs/pSOX9 nanoparticles had a SOX9 expression level 
comparable to that of the Lipofectamine2000, which was significantly higher than that of the transfection reagent 
PEI (25 kDa) (Fig. 2c). Furthermore, the CDs/pSOX9 nanoparticles possessed considerably enhanced transfection 
efficiency than the PEI-CDs/pDNA complexes (Fig. 2d). PEI, a widely used cationic polymer gene carrier easily 
attached into cells, has a high transfection together with high cytotoxicity. One way due that PEI make cell mem-
brane broken which lead to cell necrosis(immediate); another the mitochondrial membrane breakage of the cell 
by swallowing PEI, the cell eventually lead to apoptosis (delay). Compare with PEI, CDs with cationic and small 
size enhances pDNA attached to cell membrane without any cytotoxicity. These results suggested that the CDs 
prepared in this study could serve as a novel, highly efficient non-viral vector for gene delivery.
Subcellular localization. The dual-functional CDs prepared in this study not only possessed high 
transfection efficiency but also had the self-imaging ability. Considering that the CDs might not be able to 
enter nuclei, the green fluorescent nucleic acid dye YOYO-1 was employed to track and locate the exoge-
nous pDNA within the cells. With the laser confocal fluorescence microscopy, the translocation process of 
the CDs/pSOX9 nanoparticles and the YOYO-1-labeled CDs/pSOX9 nanoparticles in MEFs was observed 
4, 8 or 24 h after transfection. As shown in Fig. 2e,f, the plasmid DNA was clearly observed in the cyto-
plasm 8 h after transfection with the CDs/pSOX9 nanoparticles when exicted at the three wavelengthes 
(405, 488, and 514 nm), but there was no clear indication of nucleic localization of the exogenous plasmid 
Figure 2. Cytotoxicity assay and transfection efficiency. (a) Cytotoxicity of CDs/pDNA nanoparticles formed 
at various ratios (1:1, 10:1, 100:1, 500:1, and 1000:1) compared with PEI (25 kDa) (**P < 0.01); (b) Cytotoxicity 
of PEI-CDs/pDNA complexes formed at various ratios (10:1, 20:1, 100:1, 400:1, 800:1, and 1000:1); (c) In 
vitro gene transfection efficiency of CDs/pDNA nanoparticles compared with PEI (25 kDa)/pDNA and 
Lipofectamine 2000/pDNA (*P < 0.05; **P < 0.01); (d) Comparison of the transfection efficiency among CDs/
pDNA nanoparticles, PEI-CDs/pDNA complexes, PEI (25 kDa)/pDNA and free plasmid DNA; (e) Real-time 
imaging of CDs/pDNA complexes following transfection of UCDSCs. Similar conditions were applied in this 
case; (f) Real-time imaging of CDs/pDNA complexes with YOYO-1-labeled DNA following transfection of 
MEFs. The 405, 488 and 514 nm cell columns were observed 4, 8, and 24 h after transfection. Scare bars = 5 μm. 
Values are the means ± SD of three repeated experiments.
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SOX9 (Fig. 2e). On the other hand, the YOYO-1-labeled CDs/pSOX9 nanoparticles-transfected group 
showed obvious nucleic localization of the exogenous plasmid SOX9 as indicated by the green fluorescence 
emitted by YOYO-1 (Fig. 2f ). This result indicated that CDs could not enter nuclei, but the exogenous 
plasmid DNA could be successfully released from the CDs/pDNA nanoparticles and enter nuclei where the 
exogenous gene could be effectively expressed.
Cellular uptake. The mechanisms of the internalization of the CDs/pDNA complexes were investigated by 
employing four cellular uptake inhibitors: filipin III, glucose, 5-(N, N-dimethyl)-amiloride (DMA), and chlor-
promazine hydrochloride (CPZ). It is well recognized that filipin III inhibits caveolae-mediated endocytosis44, 
glucose and CPZ are typical inhibitors for clathrin-mediated endocytosis45, and DMA is known to disrupt mac-
ropinocytosis46. As shown in Fig. 3, when compared with the blank control, the fluorescence intensity in the cells 
treated with filipin III, glucose and CPZ was notably decreased, whereas the cells incubated with DMA did not 
exhibit differences in the fluorescence intensity from the blank control group. As shown in Fig. 4, when cells were 
cultivated with glucose, filipin III and CPZ, no fluorescence was emitted by the cells while cells treated with DMA 
exhibited strong fluorescent intensity. These results indicated that both caveolae- and clathrin-mediated endocy-
tosis represent the major cellular uptake mechanisms of the CDs/pDNA complexes, whereas macropinocytosis 
plays a minimal role. It is likely that multiple endocytosis pathways may lead to the high transfection efficiency of 
the CDs/pDNA complexes.
Chondrogenic differentiation. With the highly efficient expression of SOX9 which is known for induc-
tion of chondrogenesis, the chondrogenic differentiation of the transfected MEFs were assessed at various 
Figure 3. Cellular uptake analyses. MEFs observed using laser scanning confocal microscopy at excitation 
wavelengths at 405, 488 and 514 nm for blue, green and red fluorescence, respectively, following inhibition 
with filipin III, glucose, 5-(N,N-dimethyl)-amiloride (DMA), and chlorpromazine hydrochloride (CPZ). Scare 
bars = 20 μm.
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time points (day 3, 7 and 14) during the 2-week culture process. Using DAB staining (Fig. 5a), the CDs/pSOX9 
nanoparticles-transfected MEF was positive (shown as increasing color intensity when the incubation time was 
prolonged) for collagen II marker, whereas untransfected MEFs showed no expression of collagen II (blank). 
The toluidine blue staining further confirmed the gradual process of cartilage formation as shown by the grad-
ual color change from purple to fuchsia from day 3 to day 14 (Fig. 5b). The similar results of Western blot-
ting (Fig. 5c) can be seen with DAB staining for collagen II. These data demonstrated that the CDs/pSOX9 
nanoparticles-transfected MEFs could successfully differentiate into cartilage cells.
Figure 4. Flow cytometry analyses. MEFs observed using Flow cytometry at excitation wavelengths 488 for 
green fluorescence, respectively, following inhibition with filipin III, glucose, 5-(N,N-dimethyl)-amiloride 
(DMA), and chlorpromazine hydrochloride (CPZ).
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Immunogenicity test. Due to high viral vector immunogenicity and viral recombination, more researchers 
have been favoring non-viral carriers as they possess properties like noninfectious, unlimited capacity, controlled 
chemical structure and large preparation. Nevertheless, most of the non-viral carriers are less efficient, and are 
quickly eliminated from the body after their delivery. We developed a kind of small size (10 nm) gene vector and 
efficient tracer, which is small enough to escape elimination from the body and possess self-tracking ability. We 
found that the mice did not show any abnormal behavior, irritant reactions, and unaffected activities like eating. 
Meanwhile, no blood coagulation or erythrocyte aggregation effect was seen on the mice. The Mice blood cell 
counts after intravenous treatments with CDs/pSOX9 nanoparticles at concentration of 100 mg/kg for 7days, one 
dose per day (n = 3). The cells in the CBC (white blood cells, red blood cells, and platelets) have unique functions, 
which can also be done as a part of an evaluation based on symptoms. The white blood cells are an essential part 
of the immune system and help the body fight infections. Each different component of the white blood cell (the 
WBC differential) plays a specific role in the immune system. Red blood cells are essential in transporting oxygen 
to all the cells in the body to serve their functions. Platelets are a part of the blood clotting system in the body 
and help in preventing bleeding. The cell counts of CDs/pDNA groups had no appreciable different with normal 
group. The results showed the biosecurity of CDs (Table 2).
Figure 5. Identification of MEF differentiation into chondrocytes. (a) Immunohistochemical staining for 
collagen II using DAB. Blank: MEFs, 3days-14days; MEFs transfected with CDs/pDNA complexes for 3, 7 or14 
days; scare bars = 50 μm. (b) Toluidine blue staining. Blank: MEFs, 3 days-14days; MEFs transfected with CDs/
pDNA complexes for 3, 7 or14 days; (c) Western bolt results of collagen II and GAG, and β-actin was used as 
control. scare bars = 50 μm.
Figure 6. Sketch of the formation of CDs and CDs/plasmid.
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Conclusions
In this study, we prepared the CDs with low cytotoxicity by a one-step microwave- assisted pyrolysis of arginine 
and glucose, which were utilized as a novel, safe, highly efficient, dual-functional (gene delivery and self-tracking) 
cationic nano gene vector. The synthesized CDs not only had high gene transfection efficiency but also enabled 
the intracellular tracking of the delivered molecules through tunable fluorescence studies. Furthermore, the CDs/
pDNA nanoparticles could be internalized via both caveolae- and clathrin-mediated endocytosis and enter nuclei 
to achieve an effective gene expression. More importantly, the CDs-mediated delivery of plasmid SOX9 could 
successfully induce the chondrogenesis from the transfected MEFs. Taken together, the judicious application of 
the dual-functional CDs as both the non-viral gene vector and self-imaging reagent described herein holds a great 
promise for the non-viral gene delivery, tissue engineering as well as bioimaging.
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